"Anti-Retroviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Agents used to treat RETROVIRIDAE INFECTIONS.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D044966
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D27.505.954.122.388.077 
						 | 
					
					
						| Concept/Terms | 
						
							Anti-Retroviral Agents- Anti-Retroviral Agents
 - Agents, Anti-Retroviral
 - Anti Retroviral Agents
 - Antiretroviral Agents
 - Agents, Antiretroviral
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Anti-Retroviral Agents".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Anti-Retroviral Agents".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Anti-Retroviral Agents" by people in this website by year, and whether "Anti-Retroviral Agents" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2005 | 0 | 1 | 1 | 
| 2007 | 2 | 0 | 2 | 
| 2009 | 2 | 1 | 3 | 
| 2010 | 0 | 2 | 2 | 
| 2011 | 0 | 1 | 1 | 
| 2012 | 2 | 0 | 2 | 
| 2013 | 5 | 2 | 7 | 
| 2014 | 9 | 5 | 14 | 
| 2015 | 3 | 4 | 7 | 
| 2016 | 2 | 0 | 2 | 
| 2017 | 2 | 0 | 2 | 
| 2018 | 0 | 1 | 1 | 
| 2019 | 0 | 1 | 1 | 
| 2020 | 0 | 2 | 2 | 
| 2021 | 1 | 0 | 1 | 
| 2022 | 0 | 1 | 1 | 
| 2023 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Anti-Retroviral Agents" by people in Profiles.
						
					
								- 
								
Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. JAMA. 2023 01 03; 329(1):52-62.
															
								 
							
								- 
								
Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. Lancet HIV. 2022 03; 9 Suppl 1:S2.
															
								 
							
								- 
								
Alcohol Use and Antiretroviral Adherence Among Patients Living with HIV: Is Change in Alcohol Use Associated with Change in Adherence? AIDS Behav. 2021 Jan; 25(1):203-214.
															
								 
							
								- 
								
Clinic-Level Factors Associated With Time to Antiretroviral Initiation and Viral Suppression in a Large, Urban Cohort. Clin Infect Dis. 2020 10 23; 71(7):e151-e158.
															
								 
							
								- 
								
Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data. AIDS Behav. 2020 Jun; 24(6):1784-1792.
															
								 
							
								- 
								
Cervical cancer risk in women living with HIV across four continents: A multicohort study. Int J Cancer. 2020 02 01; 146(3):601-609.
															
								 
							
								- 
								
Depression and Quality of Life among Patients Living with HIV/AIDS in the Era of Universal Treatment Access in Vietnam. Int J Environ Res Public Health. 2018 12 17; 15(12).
															
								 
							
								- 
								
Antiretroviral Prescription and Viral Suppression in a Representative Sample of HIV-Infected Persons in Care in 4 Large Metropolitan Areas of the United States, Medical Monitoring Project, 2011-2013. . 2017 10 01; 76(2):158-170.
															
								 
							
								- 
								
Barriers to Universal Prescribing of Antiretroviral Therapy by HIV Care Providers in the United States, 2013-2014. . 2017 04 15; 74(5):479-487.
															
								 
							
								- 
								
Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):540-546.